Los Angeles Capital Management
IRON icon

Los Angeles Capital Management’s Disc Medicine IRON Stock Holding History

Los Angeles Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Sell
3,082
-870
-22% -$59.8K ﹤0.01% 1136
2026
Q1 		$253K Sell
3,952
-2,542
-39% -$176K ﹤0.01% 1080
2025
Q4 		$557K Buy
+6,494
New +$549K ﹤0.01% 849

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Los Angeles Capital Management's IRON Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Disc Medicine (IRON) stake by 22% in Q2 2026, selling an estimated $59.8K and leaving 3,082 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Los Angeles Capital Management first reported a position in IRON in Q4 2025 and has held it in 3 quarters since. The position peaked at $557K in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Los Angeles Capital Management held 3,082 shares of Disc Medicine worth $225K as of Q2 2026.
  • Los Angeles Capital Management sold 870 Disc Medicine shares in Q2 2026, an estimated $59.8K.
  • Disc Medicine made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1136 holding.
  • Los Angeles Capital Management first reported a position in Disc Medicine in Q4 2025 and has held it in 3 quarters since.
  • Los Angeles Capital Management's Disc Medicine position peaked at $557K in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.